TRIM75 Activators
TRIM75 activators primarily modulate pathways closely associated with ubiquitination processes in cells, indirectly influencing the activity of TRIM75. One of the central mechanisms that many of these activators exploit is the inhibition of proteasomal degradation. Agents like MG132, ALLN, and Lactacystin reduce proteasome activity, causing a buildup of ubiquitinated proteins in the cell. Such an environment necessitates an upregulated response from ubiquitin ligases, potentially leading to an increase in TRIM75 activity.
Furthermore, other activators operate by modulating distinct pathways that can indirectly interface with ubiquitination processes. For example, compounds like Forskolin and IBMX elevate cAMP levels, which are known to modulate various cellular processes, potentially influencing ubiquitination dynamics. Similarly, inhibitors of primary signaling pathways, such as PD98059 (a MEK inhibitor) and Bay 11-7082 (a NF-kB pathway inhibitor), can create cellular conditions that redirect cellular resources towards ubiquitination pathways, indirectly promoting TRIM75 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor which leads to accumulation of ubiquitinated proteins. Elevated ubiquitin levels can stimulate TRIM75 activity to address protein ubiquitination demands. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Proteasome inhibitor that can cause an upsurge in ubiquitinated proteins. This scenario can lead to an indirect activation of TRIM75 to manage ubiquitination. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels, which can modulate various cellular processes. Potential indirect influence on ubiquitination pathways could activate TRIM75. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
PI3K inhibitor. By modulating PI3K pathway, it can indirectly influence ubiquitin-related pathways, potentially prompting TRIM75 activity. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-beta receptor inhibitor. Although TGF-beta proteins were to be avoided, an inhibitor can offer an indirect method to activate TRIM75 by impacting ubiquitination pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator. By influencing SIRT1 pathway, ubiquitination processes might be altered, potentially leading to TRIM75 activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
PDE inhibitor increasing cAMP levels. Elevated cAMP can indirectly modulate ubiquitination processes, possibly activating TRIM75. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-kB pathway inhibitor. By modulating this pathway, there can be alterations in ubiquitination activities, indirectly prompting TRIM75 activity. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
PKA inhibitor which can influence cAMP-regulated pathways. This can indirectly affect ubiquitination mechanisms, leading to TRIM75 activation. | ||||||